Exelixis, Inc. - Medical Affairs
Exelixis is an oncology-focused biotechnology company that strives to accelerate the discovery, development, and commercialization of new products for difficult-to-treat cancers. Our efforts have resulted in four approved products available to patients worldwide. Our clinical development program focuses on our pipeline products as well as evaluation of cabozantinib in new tumor types and combinations. Exelixis continues to invest in expansion of our product pipeline through internal drug discovery and strategic business development opportunities.